New Options for the Prevention of Influenza
- 28 October 1999
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 341 (18), 1387-1388
- https://doi.org/10.1056/nejm199910283411809
Abstract
Influenza is a highly contagious acute respiratory disease of global importance. It is also a model of emerging and reemerging infectious diseases,1 for two reasons. First, annual epidemics of influenza are caused by viruses that have evolved sufficiently to reinfect persons who were infected by related strains that circulated previously. Second, influenza pandemics can occur unpredictably as a result of the emergence of new subtypes of influenza A viruses harbored in birds.We are faced with the near certainty that another pandemic will occur sometime in the future. This prediction is based on observations from past centuries and our current . . .Keywords
This publication has 6 references indexed in Scilit:
- Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent InfluenzaNew England Journal of Medicine, 1999
- Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human InfluenzaJAMA, 1999
- Human infection with influenza H9N2The Lancet, 1999
- Poultry and the influenza H5N1 outbreak in Hong Kong, 1997: Abridged chronology and virus isolationVaccine, 1999
- Zanamivir in the Prevention of Influenza Among Healthy AdultsJAMA, 1999
- Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitorAntiviral Research, 1998